{"podcast":{"title":"JAMA Medical News","slug":"jama-medical-news-779603","podcast_index_feed_id":779603,"rss_url":"https://jamamedicalnews.libsyn.com/rss","website_url":"https://jamanetwork.com/journals/jama/pages/jama-medical-news","image_url":"https://static.libsyn.com/p/assets/f/e/e/9/fee9315226fd0c30/MedicalNews_Podcast_Cover_Final.png","author":"American Medical Association","episode_count":290,"summary":"Discussions of timely topics in clinical medicine, biomedical research, public health, health policy, and more, featured in the Medical News section of JAMA, the Journal of the American Medical Association.","last_synced_at":"2026-06-27T04:18:01.025531+00:00","page_url":"https://stenobird.com/podcast/jama-medical-news-779603"},"episode":{"title":"New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions","slug":"new-glp-1-drug-options-and-more-highlights-from-the-ada-s-2026-scientific-sessions","published_at":"2026-06-18T15:00:00+00:00","page_url":"https://stenobird.com/podcast/jama-medical-news-779603/new-glp-1-drug-options-and-more-highlights-from-the-ada-s-2026-scientific-sessions","show_page_url":"https://stenobird.com/podcast/jama-medical-news-779603","url":"https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jama.2026.7593","audio_url":"https://traffic.libsyn.com/secure/jamamedicalnews/New_GLP-1_Drug_Options_and_More_Highlights_From_the_ADAs_2026_Scientific_Sessions_1.mp3?dest-id=525944","summary":"Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue injection, data from China on high-dose mazdutide, and more. Related Content: A New GLP-1 Pill for Diabetes, Semaglutide With Amylin, Data From China, and More From ADA 2026","meta_description":"Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1369,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/jama-medical-news-779603/episodes/new-glp-1-drug-options-and-more-highlights-from-the-ada-s-2026-scientific-sessions/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/jama-medical-news-779603/new-glp-1-drug-options-and-more-highlights-from-the-ada-s-2026-scientific-sessions.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}